These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7620835

  • 1. Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity.
    Nakano M, Kanda T, Matsuzaki S, Hasegawa S, Ma H, Imai S, Suzuki T, Kobayashi I.
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):21-30. PubMed ID: 7620835
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
    Hajj-Ali AF, Wong PC.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
    [Abstract] [Full Text] [Related]

  • 5. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]

  • 6. [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
    Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E.
    Cardiologia; 1993 Jul; 38(7):471-6. PubMed ID: 8221742
    [Abstract] [Full Text] [Related]

  • 7. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors].
    Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E.
    Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407
    [Abstract] [Full Text] [Related]

  • 8. The angiotensin II subtype 2 (AT2) receptor is linked to protein kinase C but not cAMP-dependent pathways in the cardiomyocyte.
    Rabkin SW.
    Can J Physiol Pharmacol; 1996 Feb; 74(2):125-31. PubMed ID: 8723023
    [Abstract] [Full Text] [Related]

  • 9. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB, Smith RD.
    Blood Press Suppl; 1996 Feb; 2():53-61. PubMed ID: 8913541
    [Abstract] [Full Text] [Related]

  • 10. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL.
    J Clin Invest; 1996 Jul 15; 98(2):418-25. PubMed ID: 8755652
    [Abstract] [Full Text] [Related]

  • 11. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR, Lo MW, Christ DD, Chiou R, Furtek CI, Amit O, Carides A, Biollaz J, Piguet V, Nussberger J, Brunner HR.
    Clin Pharmacol Ther; 1997 Jan 15; 61(1):59-69. PubMed ID: 9024174
    [Abstract] [Full Text] [Related]

  • 12. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB, Duncia JV, Carini DJ, Chiu AT, Wong PC, Wexler RR, Smith RD.
    J Hum Hypertens; 1995 Nov 15; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB, Black MJ, Bertram JF, Bobik A.
    J Hypertens; 1994 Oct 15; 12(10):1163-70. PubMed ID: 7836732
    [Abstract] [Full Text] [Related]

  • 14. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P, Elghozi JL.
    Arch Mal Coeur Vaiss; 1995 Aug 15; 88(8):1203-7. PubMed ID: 8572874
    [Abstract] [Full Text] [Related]

  • 15. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
    Niederberger M, Aubert JF, Nussberger J, Brunner HR, Waeber B.
    J Hypertens; 1995 Apr 15; 13(4):439-45. PubMed ID: 7629405
    [Abstract] [Full Text] [Related]

  • 16. Developmental regulation of angiotensin type 1 and 2 receptor gene expression and heart growth.
    Everett AD, Fisher A, Tufro-McReddie A, Harris M.
    J Mol Cell Cardiol; 1997 Jan 15; 29(1):141-8. PubMed ID: 9040029
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
    Golomb E, Abassi ZA, Cuda G, Stylianou M, Panchal VR, Trachewsky D, Keiser HR.
    Am J Physiol; 1994 Oct 15; 267(4 Pt 2):H1496-506. PubMed ID: 7524366
    [Abstract] [Full Text] [Related]

  • 18. Ontogeny of cardiac ornithine decarboxylase and its beta adrenergic responsiveness in the rat.
    Miska SP, Kimmel GL, Harmon JR, Webb P.
    J Pharmacol Exp Ther; 1984 Aug 15; 230(2):419-23. PubMed ID: 6086887
    [Abstract] [Full Text] [Related]

  • 19. Effect of nonpeptide angiotensin AT-1 and AT-2 antagonists on isoproterenol-induced renin release.
    Rowland NE, Fregly MJ.
    Pharmacol Biochem Behav; 1993 Mar 15; 44(3):623-6. PubMed ID: 8451266
    [Abstract] [Full Text] [Related]

  • 20. Ontogeny of food deprivation effects on ornithine decarboxylase: ornithine decarboxylase induction by alpha and beta agonists.
    Kuhn CM, McMillian MK, Evoniuk GE, Schanberg SM.
    J Pharmacol Exp Ther; 1985 Nov 15; 235(2):361-7. PubMed ID: 2865350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.